1. Home
  2. TNON vs DCOY Comparison

TNON vs DCOY Comparison

Compare TNON & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$4.52

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$3.20

Market Cap

3.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TNON
DCOY
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.2M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
TNON
DCOY
Price
$4.52
$3.20
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
2.1M
23.2K
Earning Date
05-05-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
84.90
N/A
EPS
N/A
N/A
Revenue
$3,944,000.00
N/A
Revenue This Year
$65.95
N/A
Revenue Next Year
$50.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.35
N/A
52 Week Low
$0.13
$0.53
52 Week High
$17.84
$13.51

Technical Indicators

Market Signals
Indicator
TNON
DCOY
Relative Strength Index (RSI) 51.70 32.15
Support Level $0.56 $0.61
Resistance Level $7.15 $6.24
Average True Range (ATR) 1.29 0.27
MACD -0.37 0.04
Stochastic Oscillator 0.86 13.50

Price Performance

Historical Comparison
TNON
DCOY

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: